Physician Approaches to the Pharmacologic Treatment of Dystonia in Cerebral Palsy

Cerebral Palsy Research Network, Emma Lott, Darcy Fehlings, Rose Gelineau-Morel, Michael Kruer, Jonathan W. Mink, Sruthi P. Thomas, Steve Wisniewski, Bhooma Aravamuthan

Research output: Contribution to journalArticlepeer-review

Abstract

Cerebral palsy (CP) is the most common childhood-onset motor disability and the most common condition associated with dystonia in young people.1,2 Dystonia is a debilitating movement disorder characterized by overflow muscle activation triggered by attempted voluntary movement.2,3 It is unclear which, if any, medications used to treat dystonia in CP are effective.3 To determine the effectiveness of existing medications for dystonia in CP,4 we must first establish which medications are currently used. In this study, we queried how physicians approach pharmacologic dystonia treatment in people with CP.

Original languageEnglish
Article numbere2023065512
JournalPediatrics
Volume154
Issue number1
DOIs
StatePublished - Jul 2024

Fingerprint

Dive into the research topics of 'Physician Approaches to the Pharmacologic Treatment of Dystonia in Cerebral Palsy'. Together they form a unique fingerprint.

Cite this